Bevaris Injection 400 mg/16 ml contains Bevacizumab, a recombinant humanized monoclonal antibody that targets vascular endothelial growth factor (VEGF). It is an anti-angiogenic medicine used in combination with chemotherapy or other anticancer therapies to treat various types of advanced and metastatic cancers. By blocking the formation of new blood vessels that supply tumors, Bevacizumab helps slow tumor growth and disease progression.

Cancer cells require a continuous blood supply to obtain oxygen and nutrients for growth. Bevacizumab binds specifically to VEGF, preventing it from interacting with its receptors on the surface of blood vessels. This inhibits the development of new blood vessels (angiogenesis), reducing the blood supply to tumors and limiting their growth and spread.

Bevaris Injection is administered as an intravenous (IV) infusion under the supervision of an experienced healthcare professional in a hospital or specialized oncology center. It is commonly used as part of combination therapy for several solid tumors and has become an important component of modern cancer treatment protocols. The dosage and treatment schedule depend on the type of cancer, the patient's body weight, and the overall treatment plan determined by the oncologist.

Because Bevacizumab can affect wound healing and increase the risk of bleeding, blood clots, and high blood pressure, patients receiving treatment require regular monitoring throughout therapy. Careful assessment by a healthcare professional helps maximize therapeutic benefits while minimizing potential risks.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Bevaris Injection 400 mg/16 ml is indicated for the treatment of:

• Metastatic colorectal cancer
• Non-squamous non-small cell lung cancer (NSCLC)
• Recurrent glioblastoma
• Metastatic renal cell carcinoma
• Persistent, recurrent, or metastatic cervical cancer
• Epithelial ovarian, fallopian tube, and primary peritoneal cancer
• Other approved oncology indications as determined by an oncologist

How Bevaris Injection Works

Bevacizumab is a monoclonal antibody that binds to vascular endothelial growth factor (VEGF). By blocking VEGF, it prevents the formation of new blood vessels that tumors need for growth and survival. This anti-angiogenic effect slows tumor growth, reduces tumor blood supply, and enhances the effectiveness of other anticancer treatments.

Benefits of Bevaris Injection

• Inhibits tumor blood vessel formation.
• Slows the growth and spread of various cancers.
• Enhances the effectiveness of chemotherapy in selected cancers.
• Helps prolong progression-free survival in appropriate patients.
• Targets VEGF with a specific mechanism of action.
• Used in several established oncology treatment protocols.
• Administered under specialist supervision for optimal cancer care.

Dosage and Administration

Bevaris Injection should be administered only by qualified healthcare professionals experienced in cancer treatment.

• Given as an intravenous infusion.
• The dose is calculated according to body weight, cancer type, and treatment protocol.
• It may be administered alone or in combination with chemotherapy or other targeted therapies.
• Patients should be monitored during and after infusion for infusion-related reactions and other adverse effects.

Treatment duration depends on disease response, tolerance, and the treating oncologist's recommendations.

Possible Side Effects

Like all medicines, Bevaris Injection may cause side effects, although not everyone experiences them.

Common side effects include:

• High blood pressure
• Fatigue
• Headache
• Nosebleeds
• Protein in the urine
• Loss of appetite
• Diarrhea

Serious side effects may include:

• Gastrointestinal perforation
• Severe bleeding
• Blood clots
• Delayed wound healing
• Heart failure
• Kidney problems
• Infusion-related reactions
• Severe allergic reactions

Seek immediate medical attention if you experience severe abdominal pain, chest pain, sudden shortness of breath, heavy bleeding, severe headache, or swelling of the face or throat.

Precautions and Warnings

Before receiving Bevaris Injection, inform your healthcare provider if you have:

• High blood pressure
• Heart disease
• Kidney disease
• Bleeding disorders
• Recent surgery or planned surgery
• History of blood clots or stroke
• Pregnancy or plans to become pregnant
• Breastfeeding

Bevacizumab may impair wound healing. Treatment is generally withheld before and after major surgery according to your physician's recommendations.

Regular monitoring of blood pressure, urine protein, kidney function, and overall clinical status is recommended during treatment.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage

Store refrigerated at 2°C to 8°C. Do not freeze or shake the vial. Keep the vial in its original carton to protect it from light. Keep out of the reach of children.

Disclaimer

Bevaris Injection 400 mg/16 ml is a prescription anticancer medicine that should only be administered under the supervision of qualified oncology specialists. Treatment requires careful monitoring for adverse effects and should be used strictly according to the prescribed treatment protocol.